KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Common Equity (2016 - 2026)

Bristol Myers Squibb has reported Common Equity over the past 18 years, most recently at $20.1 billion for Q1 2026.

  • Quarterly Common Equity rose 24.81% to $20.1 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $20.1 billion through Mar 2026, up 24.81% year-over-year, with the annual reading at $18.5 billion for FY2025, 24.1% up from the prior year.
  • Common Equity was $20.1 billion for Q1 2026 at Bristol Myers Squibb, up from $18.5 billion in the prior quarter.
  • Over five years, Common Equity peaked at $46.1 billion in Q2 2025 and troughed at -$43.7 billion in Q2 2024.
  • The 5-year median for Common Equity is $16.1 billion (2025), against an average of $15.1 billion.
  • Year-over-year, Common Equity skyrocketed 80047.37% in 2023 and then plummeted 196.45% in 2024.
  • A 5-year view of Common Equity shows it stood at $57.0 million in 2022, then skyrocketed by 80047.37% to $45.7 billion in 2023, then plummeted by 67.36% to $14.9 billion in 2024, then increased by 24.1% to $18.5 billion in 2025, then increased by 8.62% to $20.1 billion in 2026.
  • Per Business Quant, the three most recent readings for BMY's Common Equity are $20.1 billion (Q1 2026), $18.5 billion (Q4 2025), and $18.6 billion (Q3 2025).